Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Applied DNA Sciences Inc APDN

Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic... see more

Recent & Breaking News (NDAQ:APDN)

Applied DNA Secures Amendment to Master Services Agreement and Fourth Blanket Purchase Order from Linea(TM) COVID-19 Assay Kit Customer

Business Wire April 26, 2021

Applied DNA Provides Preliminary Estimated Fiscal Second Quarter 2021 Revenue Range and Business Update

Business Wire April 21, 2021

Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA(TM) COVID-19 Vaccine Candidate in Felines

Business Wire April 12, 2021

Applied DNA CEO Discusses Relevance of DNA-based Cotton Traceability as Enabler of Ethical and Responsible Textile Manufacturing on BBC Business Daily

Business Wire April 8, 2021

Applied DNA and Northwell Health Establish SARS-CoV-2 Mutation and Variant Tracking Program

Business Wire April 7, 2021

Applied DNA Appoints Clay Shorrock as Chief Legal Officer and Executive Director of Business Development

Business Wire April 1, 2021

Applied DNA Receives Blanket Purchase Order for Linea(TM) COVID-19 Assay Kits for 10,000 Tests

Business Wire March 11, 2021

Applied DNA Launches Linea(TM) COVID-19 Selective Genomic Surveillance(TM) Mutation Panel to Boost SARS-CoV-2 Variant Detection and Tracking Nationally

Business Wire March 9, 2021

Applied DNA to Participate in Upcoming Conferences

Business Wire March 8, 2021

Applied DNA and Evvivax Initiate Phase I of Clinical Trial to Evaluate LinearDNA(TM) COVID-19 Vaccine Candidate for Feline Veterinary Market

Business Wire March 2, 2021

Applied DNA Granted U.S. Patent Covering Methods of Utilizing DNA Tagged Submicron Particles for Authentication

Business Wire February 25, 2021

Applied DNA to Provide Back-To-Campus COVID-19 Surveillance Testing to LIM College

Business Wire February 19, 2021

Applied DNA Reports First Fiscal Quarter 2021 Revenues at Upper End of Guided Range

Business Wire February 11, 2021

Applied DNA and Cytocheck Detect First Instance of SARS-CoV-2 B.1.1.7 Variant in Kansas

Business Wire February 11, 2021

Applied DNA Schedules Fiscal 2021 First Quarter Financial Results Conference Call and Webcast for Thursday, February 11, 2021

Business Wire February 5, 2021

Applied DNA Achieves Program Milestone in Development of Linear DNA Veterinary COVID-19 Vaccine

Business Wire February 2, 2021

TruTrace Technologies(TM) and Applied DNA Unveil Complete Cannabis Product Validation and Authentication Solution

Business Wire January 26, 2021

Applied DNA and TruTrace Technologies(TM) Unveil Complete Cannabis Product Validation and Authentication Solution

Business Wire January 26, 2021

Applied DNA Promotes Judith Murrah to Chief Operating Officer

Business Wire January 20, 2021

Applied DNA Linea(TM) COVID-19 Assay Kit Demonstrates Effectiveness with Detection of Multiple SARS-CoV-2 Variants During Recent Surveillance Testing

Business Wire January 19, 2021